MedPath

Effects of Citicoline in Patients with Head Trauma

Phase 2
Conditions
Head Trauma.
Diffuse brain injury
Registration Number
IRCT201112191840N2
Lead Sponsor
euroscience Research Center (NSRC), Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
40
Inclusion Criteria

Inclusion Criteria: 1) 18-65 years of age. 2) Providing informed consent to be included in the study. 3) Absence of major traumatic lesion in chest, abdomen or limbs. 4) Admission within 24 hours following trauma. 5) Absence of major cardiac diseases. 6) Absence of cardiac disease, hyperlipidemia, diabetes and hypertension.
Exclusion criteria: 1) Admission after 24 hours following the trauma. 2) History of heart disease, hyperlipidemia, diabetes, hypertension and coagulation disorders. 3) History of malignancy. 4) Multitrauma patients with major trauma of chest, abdomen or limbs. 5) Patients with focal brain lesions such as contusion and brain hematoma which necessitates surgical drainage. 7) Unstable hemodynamic. 8) Pregnancy. 9) Surgery including general, orthopedic or gynecologic surgeries within first 24 hours after trauma. 10) CPR or resuscitation within 24 hours after trauma. 11) Death or discharge within study period.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fetuin-A. Timepoint: 1st(Before intervention), 6th day(After intervention) and 12th day(After intervention). Method of measurement: Plasma levels.;Matrix Gla Protein (MGP). Timepoint: 1st(Before intervention), 6th(After intervention), 12th day(After intervention). Method of measurement: Plasma levels.;Level of Consciousness. Timepoint: Daily(From the first day of admission to the last day of study). Method of measurement: Assessment of GCS by examiner.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath